These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
92 related articles for article (PubMed ID: 12019504)
1. Extent of ductal carcinoma in situ within and surrounding invasive primary breast carcinoma (Br J Surg 2001;88:1324-9). Moorthy K Br J Surg; 2002 May; 89(5):626-7; author reply 627. PubMed ID: 12019504 [No Abstract] [Full Text] [Related]
2. Meta-analysis of sentinel node biopsy in ductal carcinoma in situ of the breast (Br J Surg 2008; 95: 547-554). Meijnen P; Rutgers EJ Br J Surg; 2008 Oct; 95(10):1305; author reply 1305. PubMed ID: 18763257 [No Abstract] [Full Text] [Related]
3. Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma. Castro NP; Osório CA; Torres C; Bastos EP; Mourão-Neto M; Soares FA; Brentani HP; Carraro DM Breast Cancer Res; 2008; 10(5):R87. PubMed ID: 18928525 [TBL] [Abstract][Full Text] [Related]
4. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Bofin AM; Lydersen S; Hagmar BM Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908 [TBL] [Abstract][Full Text] [Related]
5. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ. Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD Breast J; 2007; 13(6):545-50. PubMed ID: 17983393 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of ductal carcinoma in-situ of breast and its correlation with the grade of associated invasive component. Konar K; Chatterjee U; Dutta SK Indian J Pathol Microbiol; 2001 Jul; 44(3):297-300. PubMed ID: 12024916 [TBL] [Abstract][Full Text] [Related]
7. Id-1 overexpression in invasive ductal carcinoma cells is significantly associated with intratumoral microvessel density in ER-negative/node-positive breast cancer. Jang KS; Han HX; Paik SS; Brown PH; Kong G Cancer Lett; 2006 Dec; 244(2):203-10. PubMed ID: 16469432 [TBL] [Abstract][Full Text] [Related]
8. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Kominsky SL; Argani P; Korz D; Evron E; Raman V; Garrett E; Rein A; Sauter G; Kallioniemi OP; Sukumar S Oncogene; 2003 Apr; 22(13):2021-33. PubMed ID: 12673207 [TBL] [Abstract][Full Text] [Related]
9. The incidence and significance of micrometastases in lymph nodes of patients with ductal carcinoma in situ and T1a carcinoma of the breast. Broekhuizen LN; Wijsman JH; Peterse JL; Rutgers EJ Eur J Surg Oncol; 2006 Jun; 32(5):502-6. PubMed ID: 16569492 [TBL] [Abstract][Full Text] [Related]
10. Are encapsulated papillary carcinomas of the breast in situ or invasive? A basement membrane study of 27 cases. Esposito NN; Dabbs DJ; Bhargava R Am J Clin Pathol; 2009 Feb; 131(2):228-42. PubMed ID: 19141383 [TBL] [Abstract][Full Text] [Related]
11. E-cadherin expression in pleomorphic lobular carcinoma: an aid to differentiation from ductal carcinoma. Wahed A; Connelly J; Reese T Ann Diagn Pathol; 2002 Dec; 6(6):349-51. PubMed ID: 12478484 [TBL] [Abstract][Full Text] [Related]
12. Similar long-term results of breast-conservation treatment for Stage I and II invasive lobular carcinoma compared with invasive ductal carcinoma of the breast: The University of Pennsylvania experience. Santiago RJ; Harris EE; Qin L; Hwang WT; Solin LJ Cancer; 2005 Jun; 103(12):2447-54. PubMed ID: 15887223 [TBL] [Abstract][Full Text] [Related]
13. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast. Cheung KJ; Tam W; Chuang E; Osborne MP Breast J; 2007; 13(4):413-7. PubMed ID: 17593048 [TBL] [Abstract][Full Text] [Related]
14. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types. Iacobuzio-Donahue CA; Argani P; Hempen PM; Jones J; Kern SE Cancer Res; 2002 Sep; 62(18):5351-7. PubMed ID: 12235006 [TBL] [Abstract][Full Text] [Related]
15. Do sentinel node micrometastases predict recurrence risk in ductal carcinoma in situ and ductal carcinoma in situ with microinvasion? Murphy CD; Jones JL; Javid SH; Michaelson JS; Nolan ME; Lipsitz SR; Specht MC; Lesnikoski BA; Hughes KS; Gadd MA; Smith BL Am J Surg; 2008 Oct; 196(4):566-8. PubMed ID: 18760400 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of scoring system based on histological heterogeneity of invasive ductal carcinoma for node-negative breast cancer patients. Kurosumi M; Tabei T; Inoue K; Takei H; Ninomiya J; Naganuma R; Suemasu K; Higashi Y; Tsuchiya E Oncol Rep; 2003; 10(4):833-7. PubMed ID: 12792731 [TBL] [Abstract][Full Text] [Related]
17. Value of sentinel lymph node biopsy in breast ductal carcinoma in situ upstaged to invasive carcinoma. Sakr R; Antoine M; Barranger E; Dubernard G; Salem C; Daraï E; Uzan S Breast J; 2008; 14(1):55-60. PubMed ID: 18186866 [TBL] [Abstract][Full Text] [Related]
18. LEA.135 expression: identifies low-risk patients with breast ductal carcinoma in situ. Baltayan A; Naritoku WY; Chaiwun B; Tsao-Wei DD; Groshen S; Hern RA; Gusterson BA; Taylor CR; Imam SA Anticancer Res; 2002; 22(5):2933-7. PubMed ID: 12530020 [TBL] [Abstract][Full Text] [Related]
19. Evidence of chromosomal alterations in pure usual ductal hyperplasia as a breast carcinoma precursor. Xu S; Wei B; Zhang H; Qing M; Bu H Oncol Rep; 2008 Jun; 19(6):1469-75. PubMed ID: 18497952 [TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins. Dzierzanowski M; Melville KA; Barnes PJ; MacIntosh RF; Caines JS; Porter GA J Surg Oncol; 2005 May; 90(2):71-6. PubMed ID: 15844190 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]